10 épisodes

The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures.

But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives.

Where will the next breakthroughs come from? How will we pay for them? Who decides who gets them?

This is SIGNAL, a podcast from Stat that sorts through the flood of health and medical news to deliver stories of the next development, controversy or breakthrough that will affect us all. Hosted by veteran biotech journalist Luke Timmerman and CNBC biotech and pharma reporter Meg Tirrell, SIGNAL explores the characters and the dramas behind today’s medicine, from biotech boardrooms, to research labs, to your corner pharmacy. Subscribe to us on iTunes and Stitcher, or visit us on our website, www.statnews.com.

Signal Stat

    • Sciences

The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures.

But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives.

Where will the next breakthroughs come from? How will we pay for them? Who decides who gets them?

This is SIGNAL, a podcast from Stat that sorts through the flood of health and medical news to deliver stories of the next development, controversy or breakthrough that will affect us all. Hosted by veteran biotech journalist Luke Timmerman and CNBC biotech and pharma reporter Meg Tirrell, SIGNAL explores the characters and the dramas behind today’s medicine, from biotech boardrooms, to research labs, to your corner pharmacy. Subscribe to us on iTunes and Stitcher, or visit us on our website, www.statnews.com.

    Episode #14 - These hamsters have birthed billions for biotech

    Episode #14 - These hamsters have birthed billions for biotech

    The Chinese hamster has led a secret life in science for decades. By one estimate, 11 biotech drugs that are made using Chinese hamster ovary cells generated an incredible $57 billion in sales in 2013. That's pretty incredible, given the hamster's humble beginnings as a pest in Chinese fields. Listen to learn how something so small got so big.

    This Signal podcast was produced by Jocelyn Gonzales. Illustration by Molly Ferguson for STAT.

    • 20 min
    Episode #13 - The superbugs are quietly amassing their forces -- and we're helping them

    Episode #13 - The superbugs are quietly amassing their forces -- and we're helping them

    A deadly new superbug is just starting to surface worldwide. Who is to blame for its rise? Well, us, really. Public health officials are warning we could be headed toward a post-antibiotics world, unless we do something, and fast. So where does Signal start to tackle this story? Inside a cave, of course.

    This Signal podcast was produced by Katie Hiler. Illustration by Molly Ferguson for STAT.

    • 24 min
    Episode #12 - Before you pop that Tylenol, listen to this podcast

    Episode #12 - Before you pop that Tylenol, listen to this podcast

    How confident are you that the drugs you take, whether they're over-the-counter or prescription, are totally understood by the companies who make them? Drug makers know what their products do when they enter your body, right? You shouldn't assume that.

    In this episode of Signal, we talk everything from Tylenol to fen-phen to Viagra and why you should probably think hard before you take any drug at all.

    This Signal podcast was produced by Katie Hiler. Illustration by Molly Ferguson for STAT.

    • 25 min
    Episode #11 - Sexism in biotech, from scantily clad models to how gender affects this podcast

    Episode #11 - Sexism in biotech, from scantily clad models to how gender affects this podcast

    In this episode of Signal, we take on a subject that might make some of our listeners feel uncomfortable — but more importantly, it should make some of our listeners feel heard. This time we talk sexism in biotech.

    Most of us would like to work in places where equality is reality. But in the many conversations we had putting this show together with women across the industry, it seems biotech has a long road still to walk.

    The Signal podcast is produced by Katie Hiler. Illustration by Molly Ferguson for STAT.

    • 21 min
    Episode #10 - Cancer is a low-down, dirty gangster ninja

    Episode #10 - Cancer is a low-down, dirty gangster ninja

    Cancer plays dirty. Like a gangster. That's how it wins. Over the past few years, scientists have been learning its tricks and tactics. They've learned that it’s a master of adaptation, of escape, of armor, and of stealth -- so maybe it's more of a disease ninja than disease gangster. Maybe you should listen and decide for yourself.

    The Signal podcast is produced by Katie Hiler. Illustration by Molly Ferguson for STAT.

    • 23 min
    Episode #9 - What should you most fear? Sharks, killer snails or the flu?

    Episode #9 - What should you most fear? Sharks, killer snails or the flu?

    How do our perceptions of risk, and our outsized — or undersized — fears affect our health? In this episode of Signal we explore the killer snail (flu) and the shark (cancer screening) of medicine.

    (It's a metaphor, people.)

    The Signal podcast is produced by Katie Hiler. Illustration by Molly Ferguson for STAT.

    • 23 min

Classement des podcasts dans Sciences

In utero
France Inter
Votre cerveau
France Culture
La science, CQFD
France Culture
Y'a plus de saisons
Swann Périssé / Binge Audio
La Conversation scientifique
France Culture
Neurosapiens
Neurosapiens